Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Samsung adds native AirDrop support to Galaxy S26 devices

March 23, 2026

Brian Ferdinand Portfolio Manager of EverForward Trading Joins Forbes Business Development Council, Marking Key Milestone for EverForward Trading

March 23, 2026

General (Ret.) Christopher Cavoli, Former EUCOM Commander and Supreme Allied Commander Europe, Joins Pallas Speakers Bureau

March 23, 2026

Bunker Hill Announces Graduation to the Toronto Stock Exchange and on Track for Restart of Operations in June 2026

March 23, 2026

MEXC and Ondo Finance Expand Tokenized Stock Partnership with 19 New Spot Pairs and Zero-Fee Trading

March 23, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home ยป Organs-on-Chip Industry Research Report 2023-2028: A $392 Million Global Market Opportunity, Driven by the Upsurge in Demand for Reduction in Animal Testing and Increased Personalization in Medicine
Press Release

Organs-on-Chip Industry Research Report 2023-2028: A $392 Million Global Market Opportunity, Driven by the Upsurge in Demand for Reduction in Animal Testing and Increased Personalization in Medicine

By News RoomJanuary 25, 20243 Mins Read
Organs-on-Chip Industry Research Report 2023-2028: A 2 Million Global Market Opportunity, Driven by the Upsurge in Demand for Reduction in Animal Testing and Increased Personalization in Medicine
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) — The “Organs on Chip Market – Forecasts from 2023 to 2028” report has been added to ResearchAndMarkets.com’s offering.

The report indicates that the organs-on-chip market is seeing rapid expansion, with projections placing its value at an estimated US$392.621 million by 2028, growing from US$74.827 million in 2021. This remarkable growth is attributed to a compound annual growth rate (CAGR) of 26.72% during the forecast period from 2023 to 2028.

Organ-on-a-chip technology, representing micro-engineered systems that simulate physiological responses of organ tissues, is gaining significant traction as a critical tool in drug discovery and development. An upsurge in demand for reduction in animal testing and increased personalization in medicine are driving factors bolstering market growth.

While this innovative approach has the potential to revolutionize many aspects of medical research, certain challenges such as the intricacy of emulating complex organ functions and high costs could impede market progression. Nevertheless, strategic collaborations and growing investment in R&D are smoothing the way for advancements in the field.

The report encompasses an exhaustive analysis segmented by type, application, offerings, and end-user, alongside regional insights.

  • Liver, kidney, lung, heart, and other types of organ-on-a-chip are detailed.
  • Utility across drug discovery, toxicity testing, and physiological modeling applications is explored.
  • Products and services constitute the market’s offering scope.
  • End-user analysis covers both research institutes and pharmaceutical companies.

Essential for understanding sector dynamics, the study employs Porter’s Five Forces Model and industry value chain analysis. It further delves into market regulations and outlines the regulatory landscape affecting the organs-on-chip industry, assisting stakeholders in comprehending factors influential to market environment.

A section of the study provides a 360-degree view of the demand across varied geographic regions such as the Americas, Europe, the Middle East and Africa, and the Asia Pacific, highlighting country-specific insights.

The competitive landscape is rigorously analyzed, presenting strategies from market leaders, followers, challengers, to niche players, classified within an intricate vendor matrix. This research contributes crucial market insights to executives and interested parties, aiding in strategic decision-making processes.

The extensive report on the organs-on-chip market, armed with detailed insights, is a definitive guide to understanding current trends, growth drivers, and industry challenges from 2023 to 2028. It is an invaluable tool for stakeholders looking to navigate this burgeoning market with confidence.

Market Segmentation Reveals Key Growth Opportunities

  1. The liver segment is positioned prominently and shows significant growth potential.
  2. Increased emphasis on drug discovery applications spurs market demand.
  3. Investment in organ-on-chip service offerings reflects the market’s trajectory towards providing comprehensive solutions.

As the organs-on-chip market continues to expand, stakeholders can expect to see a surging influence on the overall landscape of drug development and biomedical research, heralding a new era of personalized medicine and ethical testing practices.

Key Attributes

Report Attribute Details
No. of Pages 117
Forecast Period 2021-2028
Estimated Market Value (USD) in 2021 $74.83 Million
Forecasted Market Value (USD) by 2028 $392.62 Million
Compound Annual Growth Rate 26.7%
Regions Covered Global

Companies Mentioned

  • AxoSim Inc.
  • BiomimX SRL
  • CN Bio
  • Emulate Inc.
  • InSphero AG
  • MIMETAS B.V.
  • Nortis Inc.
  • TissUse GmbH

For more information about this report visit https://www.researchandmarkets.com/r/ux3h5y

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Brian Ferdinand Portfolio Manager of EverForward Trading Joins Forbes Business Development Council, Marking Key Milestone for EverForward Trading

General (Ret.) Christopher Cavoli, Former EUCOM Commander and Supreme Allied Commander Europe, Joins Pallas Speakers Bureau

Bunker Hill Announces Graduation to the Toronto Stock Exchange and on Track for Restart of Operations in June 2026

MEXC and Ondo Finance Expand Tokenized Stock Partnership with 19 New Spot Pairs and Zero-Fee Trading

McEwen Reports Tartan Mine Project Gold Mineral Resource Estimate

Spectrum Plasma Receives 2026 Global Recognition Award

West Red Lake Gold Added To GDXJ Junior Gold Miners ETF

Philips convenes the Annual General Meeting of Shareholders 2026

Anaveon appoints Biotech Leader Thaminda Ramanayake as Chief Executive Officer

Editors Picks

Brian Ferdinand Portfolio Manager of EverForward Trading Joins Forbes Business Development Council, Marking Key Milestone for EverForward Trading

March 23, 2026

General (Ret.) Christopher Cavoli, Former EUCOM Commander and Supreme Allied Commander Europe, Joins Pallas Speakers Bureau

March 23, 2026

Bunker Hill Announces Graduation to the Toronto Stock Exchange and on Track for Restart of Operations in June 2026

March 23, 2026

MEXC and Ondo Finance Expand Tokenized Stock Partnership with 19 New Spot Pairs and Zero-Fee Trading

March 23, 2026

Latest News

McEwen Reports Tartan Mine Project Gold Mineral Resource Estimate

March 23, 2026

Spectrum Plasma Receives 2026 Global Recognition Award

March 23, 2026

West Red Lake Gold Added To GDXJ Junior Gold Miners ETF

March 23, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version